The purpose of the company is to hold participations in pharmaceutical and chemical companies as well as in other companies of all kinds at home and abroad. The company can establish branches and subsidiaries at home and abroad, participate in other companies of all kinds at home and abroad, take over representations and exercise any business activity and conclude contracts of any kind that may be beneficial to the company's purpose or are directly or indirectly related to the company's purpose. The company can acquire, hold, manage, encumber and sell real estate at home and abroad. Excluded are transactions that are prohibited by the Federal Act on the Acquisition of Real Estate by Persons Abroad (BewG). The company is economically, organizationally and legally part of a group of companies (conglomerate) and can take into account the legitimate interests of the group when pursuing its corporate purpose. Within the framework of the legal provisions, the company directs its activities towards the conglomerate and takes into account, in particular, also intra-group instructions. In particular, the company can grant loans and other direct or indirect financing to its direct and indirect subsidiaries and third parties, including its direct and indirect shareholders and their direct and indirect subsidiaries, including within the framework of cash pooling agreements (including zero balancing), and provide security of all kinds for the liabilities of these parties, including by way of pledges on or fiduciary transfers of the company's assets or guarantees of any kind. This also without consideration, on preferential terms, without interest, to the exclusion of the company's profitability and/or by assuming cluster risks.